Literature DB >> 10955676

GDNF induces recovery of the nigrostriatal dopaminergic system in the rat brain following intracerebroventricular or intraparenchymal administration.

M Aoi1, I Date, S Tomita, T Ohmoto.   

Abstract

BACKGROUND: Glial cell line-derived neurotrophic factor (GDNF) has been shown to be a survival and neuroprotective factor for nigrostriatal dopaminergic neurons in vivo. The present study was designed to investigate the possible neuroprotective and restorative role by GDNF for dopaminergic neurons which were exposed to the neurotoxin 6-hydroxydopamine (6-OHDA).
METHOD: We compared neurochemical, morphological and behavioural changes following striatal infusion of GDNF to those following intracerebroventricular (i.c.v.) infusion.
FINDINGS: Apomorphine-induced rotation showed significant recovery after both types of infusion. Significant recovery of tyrosine hydroxylase (TH)-immunoreactive (IR) neurons and fibers were found in the substantia nigra and striatum following both striatum and i.c.v. infusion except for the number of TH-IR neurons in the i.c.v. infusion group.
INTERPRETATION: These results suggest that GDNF induces recovery of the nigrostriatal dopaminergic system, and this indicates a potential usefulness of GDNF for the treatment of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955676     DOI: 10.1007/s007010070096

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  Availability of Pre- and Pro-regions of Transgenic GDNF Affects the Ability to Induce Axonal Sprout Growth.

Authors:  Nadezda Kust; Dmitri Panteleev; Ilya Mertsalov; Ekaterina Savchenko; Ekaterina Rybalkina; Alexander Revishchin; Galina Pavlova
Journal:  Mol Neurobiol       Date:  2014-07-03       Impact factor: 5.590

2.  Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain.

Authors:  Luciana Gravotta; Alex M Gavrila; Suzanne Hood; Shimon Amir
Journal:  J Mol Neurosci       Date:  2011-04-12       Impact factor: 3.444

Review 3.  Neurological disorders and neural regeneration, with special reference to Parkinson's disease and cerebral ischemia.

Authors:  Isao Date; Takao Yasuhara
Journal:  J Artif Organs       Date:  2009-03-29       Impact factor: 1.731

Review 4.  Regenerative medicine for Parkinson's disease.

Authors:  Takao Yasuhara; Masahiro Kameda; Takashi Agari; Isao Date
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-01-23       Impact factor: 1.742

Review 5.  Neuroprotective Surgical Strategies in Parkinson's Disease: Role of Preclinical Data.

Authors:  Napoleon Torres; Jenny Molet; Cecile Moro; John Mitrofanis; Alim Louis Benabid
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

6.  GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson's Disease.

Authors:  Shoujia Sun; Quan Zhang; Man Li; Pan Gao; Kuan Huang; Rajluxmee Beejadhursing; Wei Jiang; Ting Lei; Mingxin Zhu; Kai Shu
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.